Inventor · disambiguated record
Gan Wang
Also filed as: WANG GAN
32 granted patents·10 pending applications·500 citations·filing 1995–2017
97Inventor score
Files withBRISTOL MYERS SQUIBB CO14BAYER PHARMACEUTICALS CORP7BACHAND CAROL4BAYER HEALTHCARE LLC4BENDER JOHN A2
Top patents by PatentIndex Score
42 records- 0198US7741347B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 22, 2010·52 cites·13 claims
- 0297US8303944B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2008·Granted Nov 6, 2012·36 cites·13 claims
- 0397US7704992B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 27, 2010·58 cites·25 claims
- 0496US7745636B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 29, 2010·53 cites·26 claims
- 0595US8574563B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Nov 5, 2013·18 cites·26 claims
- 0694US7838524B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerBAYER HEALTHCARE LLC·Filed 2005·Granted Nov 23, 2010·50 cites·37 claims
- 0792US8846023B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 30, 2014·7 cites·13 claims
- 0891US8207166B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerLEE WENDY·Filed 2010·Granted Jun 26, 2012·24 cites·6 claims
- 0991US8147818B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Apr 3, 2012·22 cites·22 claims
- 1090US8377980B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Feb 19, 2013·22 cites·16 claims
- 1187US6960601B2Preparation and use of imidazole derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Nov 1, 2005·26 cites·8 claims
- 1286US7511048B2PyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Mar 31, 2009·4 cites·10 claims
- 1386US7091228B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Aug 15, 2006·18 cites·20 claims
- 1485US6660181B2Inhibition of polymerization of unsaturated monomersCROMPTON CORP·Filed 2002·Granted Dec 9, 2003·20 cites·17 claims
- 1584US8552047B2Hepatitis C virus inhibitorsBENDER JOHN A·Filed 2012·Granted Oct 8, 2013·6 cites·19 claims
- 1682US8093243B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Jan 10, 2012·5 cites·26 claims
- 1781US9776981B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·2 cites·14 claims
- 1881US9561212B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 7, 2017·3 cites·16 claims
- 1980US7928227B22-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Apr 19, 2011·10 cites·28 claims
- 2079US7968576B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesitySMITH ROGER A·Filed 2008·Granted Jun 28, 2011·3 cites·15 claims
- 2178US8076488B2Bicyclic urea derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2004·Granted Dec 13, 2011·10 cites·32 claims
- 2277US8431695B2Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseasesO'CONNOR STEPHEN·Filed 2006·Granted Apr 30, 2013·5 cites·6 claims
- 2375US8796466B2Hepatitis C virus inhibitorsBENDER JOHN A·Filed 2010·Granted Aug 5, 2014·3 cites·4 claims
- 2474US7423156B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Sep 9, 2008·1 cites·20 claims
- 2570US8580798B2Substituted pyrimidine derivatives useful in the treatment of cancer and other disordersSMITH ROGER·Filed 2006·Granted Nov 12, 2013·1 cites·21 claims
- 2666US8013166B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER HEALTHCARE LLC·Filed 2008·Granted Sep 6, 2011·0 cites·18 claims
- 2765US2009197795A1Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER HEALTHCARE LLC·Filed 2008·Application pending·0 cites
- 2864US2009186887A1Novel pyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 2963US5645991ATransposon-containing DNA cloning vector and uses thereofUNIV CONNECTICUT·Filed 1995·Granted Jul 8, 1997·22 cites·19 claims
- 3062US2017355689A1Hepatitis c virus inhibitorBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 3161US9758487B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 12, 2017·0 cites·15 claims
- 3261US2013115193A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 3360US6300533B1Inhibition of polymerization of ethylenically unsaturated monomersUNIROYAL CHEM CO INC·Filed 1999·Granted Oct 9, 2001·19 cites·9 claims
- 3456US2011274648A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 3555US2015197499A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3649US2015252028A1Hepatitis c virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 3749US2005256167A1Preparation and use of imidazole derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 3846US10617675B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·9 claims
- 3944US2009215780A1Preparation and Use of Aryl Alkyl Acid Derivatives for the Treatment of ObesityBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 4041US9546160B2Hepatitis C virus inhibitorsCHEN QI·Filed 2012·Granted Jan 17, 2017·0 cites·18 claims
- 4137US10221129B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Granted Mar 5, 2019·0 cites·20 claims
- 4235US2018072997A1Inhibitors of human immunodeficiency virus replicationVIIV HEATHCARE UK NO 5 LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gan Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →